335 related articles for article (PubMed ID: 2889299)
41. [Peptic ulcer: new aspects of conservative therapy].
Bernoulli R
Schweiz Med Wochenschr; 1977 May; 107(18):618-22. PubMed ID: 17157
[TBL] [Abstract][Full Text] [Related]
42. Omeprazole: a pharmacoeconomic evaluation of its use in duodenal ulcer and reflux oesophagitis.
Barradell LB; McTavish D
Pharmacoeconomics; 1993 Jun; 3(6):482-510. PubMed ID: 10146883
[TBL] [Abstract][Full Text] [Related]
43. [Omeprazole and maintenance treatment: new concepts for traditional therapies?].
Díaz de Rojas F; Ponce García J
An Med Interna; 1992 Sep; 9(9):450-4. PubMed ID: 1391583
[TBL] [Abstract][Full Text] [Related]
44. Treatment of acid-peptic diseases by inhibition of gastric H+,K+-ATPase.
McArthur KE; Jensen RT; Gardner JD
Annu Rev Med; 1986; 37():97-105. PubMed ID: 3010811
[TBL] [Abstract][Full Text] [Related]
45. The clinical safety of omeprazole.
Sölvell L
Scand J Gastroenterol Suppl; 1989; 166():106-10; discussion 111-3. PubMed ID: 2690327
[TBL] [Abstract][Full Text] [Related]
46. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
Hentschel E
Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397
[No Abstract] [Full Text] [Related]
47. Effect of omeprazole, a substituted benzimidazole, on 24-h intragastric acidity in patients with peptic ulcer disease.
Naesdal J; Bodemar G; Walan A
Scand J Gastroenterol; 1984 Oct; 19(7):916-22. PubMed ID: 6531660
[TBL] [Abstract][Full Text] [Related]
48. Refractory peptic ulcers.
Arakawa T; Kobayashi K; Dajani EZ
J Assoc Acad Minor Phys; 1992; 3(3):95-102. PubMed ID: 1386767
[TBL] [Abstract][Full Text] [Related]
49. Controversies, dilemmas, and dialogues. Reduction of gastric acidity in the treatment of peptic ulcer disease: how low should we go?
Peterson WL; Harford WV
Am J Gastroenterol; 1991 Jun; 86(6):671-5. PubMed ID: 1674838
[No Abstract] [Full Text] [Related]
50. Recent advances in the management of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
Maton PN; Gardner JD; Jensen RT
Gastroenterol Clin North Am; 1989 Dec; 18(4):847-63. PubMed ID: 2575602
[TBL] [Abstract][Full Text] [Related]
51. H2 receptor antagonists.
Siepler JK; Campagna KD; Donahue PE; Bombeck CT
Am J Hosp Pharm; 1978 Feb; 35(2):141-5. PubMed ID: 24338
[TBL] [Abstract][Full Text] [Related]
52. Treatment of patients with Zollinger-Ellison syndrome.
Mignon M; Pospai D; Forestier S; Vatier J; Vallot T
Clin Ther; 1993; 15 Suppl B():22-31. PubMed ID: 8205592
[TBL] [Abstract][Full Text] [Related]
53. Review of peptic ulcer maintenance trials.
Robinson M
Am J Med; 1984 Nov; 77(5B):23-9. PubMed ID: 6095657
[TBL] [Abstract][Full Text] [Related]
54. [Omeprazole. A new substance for inhibiting acid production].
Uhl D
Med Monatsschr Pharm; 1990 Feb; 13(2):34-7. PubMed ID: 2179691
[No Abstract] [Full Text] [Related]
55. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
Poynard T; Lemaire M; Agostini H
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
[TBL] [Abstract][Full Text] [Related]
56. Can optimal acid suppression prevent rebleeding in peptic ulcer patients with a non-bleeding visible vessel: a preliminary report of a randomized comparative study.
Lin HJ; Lo WC; Perng CL; Wang K; Lee FY
Hepatogastroenterology; 1997; 44(17):1495-9. PubMed ID: 9356879
[TBL] [Abstract][Full Text] [Related]
57. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
Richter JE; Sabesin SM; Kogut DG; Kerr RM; Wruble LD; Collen MJ
Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695
[TBL] [Abstract][Full Text] [Related]
58. Famotidine. Pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome.
Campoli-Richards DM; Clissold SP
Drugs; 1986 Sep; 32(3):197-221. PubMed ID: 2875864
[TBL] [Abstract][Full Text] [Related]
59. Clinical development programme for omeprazole.
Walan A
Digestion; 1990; 47 Suppl 1():54-8; discussion 76. PubMed ID: 2093016
[TBL] [Abstract][Full Text] [Related]
60. Omeprazole vs. ranitidine in the short-term treatment of duodenal ulcer: an Italian multicenter study.
Barbara L; Blasi A; Cheli R; Corinaldesi R; Dobrilla G; Francavilla A; Rinetti M; Vezzaldini P; Abbiati R; Gradnik R
Hepatogastroenterology; 1987 Oct; 34(5):229-32. PubMed ID: 3315923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]